The USCACA Scholar Award 2010
The USCACA Scholar Award of Clinical, Translational and Basic
Cancer Research
Purpose
USCACA has established the USCACA Scholar Award of Clinical, Translational, and Basic Cancer Research. The purpose of this award program is to reward clinicians and basic researchers from China who performed clinical/translational or basic research in cancer under supervision of USCACA members at hospitals or research institutions in the US.
Eligibility
- The award is open to medical research professionals who have MD, PhD or MD & PhD degree from an accredited institution in China;
- A qualified candidate has conducted at least 6-month of clinical/translational or basic cancer research under the supervision of a USCACA member in the US;
- The candidate has returned to China;
- The candidate is qualified for applying for this award within one year of completing his/her training in the US
Award Categories
The award has two categories:
- Clinical/translational cancer research
- Basic cancer research
Award
4 awards of $500/per award every year
Host Training Institutions
An accredited hospitals or academic institution where a member/supervisor of USCACA is affiliated with
Nomination Process and Review
1. Nomination and Criteria
The candidate should be nominated by a member of USCACA. Self-nomination is not accepted. The nomination letter and a copy of nominee??s resume should demonstrate that the nominee has accomplished a successful training in clinical/translational or basic cancer research with evidence of high impact publication(s) (including presentations at major international conferences) or successful clinical trials/studies.
2. Letter of Support
Two letters of support should be provided for the review committee.
- A letter from nominee??s supervisor who is a member of USCACA outlining the achievements of the candidate during the training in US;
- The second letter should come from the dean or president of candidate's current institution with evidence that the candidate has returned to the home institution in China and continues to perform clinical/translational or basic cancer research.
3. Review Process
A USCACA review committee will examine the nominations. The award will be determined based on the merit and evidence of achievement of the nominee.
4. Awarded Fellows
In addition to receiving the award as indicated above, the awardees will receive an award certificate from USCACA. The award will be announced and presented in a major clinical/translational or basic cancer research meeting in either US or China. The first group of Award will be announced at the November ChinaTrial conference organized by USCACA in Beijing. The award will also be announced and posted on the website of USCACA with description of her or his achievements.
5. Nomination Dates:
The nomination date for the USCACA Scholar Exchange Award is open throughout the year.
Please send your application to chengs@UPMC.EDU